![Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS‐ONE trial - Meessen - 2020 - ESC Heart Failure - Wiley Online Library Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS‐ONE trial - Meessen - 2020 - ESC Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/103f9487-a3f1-4a1f-8fc9-721c053dfb2c/ehf212695-fig-0002-m.jpg)
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS‐ONE trial - Meessen - 2020 - ESC Heart Failure - Wiley Online Library
![Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial - European Journal of Cancer Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/589c08e8-41e2-4540-9d7a-d6cd6a8adef3/gr2.jpg)
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial - European Journal of Cancer
![Selected Abstracts from the National Congress of the Italian Society of Hypertension (SIIA 2009): 2009 October 1–4, Rome, Italy | SpringerLink Selected Abstracts from the National Congress of the Italian Society of Hypertension (SIIA 2009): 2009 October 1–4, Rome, Italy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.2165%2F11316990-000000000-00000/MediaObjects/40292_2012_16030111_Fig1.jpg)